155 related articles for article (PubMed ID: 18257091)
1. ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients.
Marchi N; Mazzone P; Fazio V; Mekhail T; Masaryk T; Janigro D
Cancer; 2008 Mar; 112(6):1313-24. PubMed ID: 18257091
[TBL] [Abstract][Full Text] [Related]
2. S100beta as a predictor of brain metastases: brain versus cerebrovascular damage.
Vogelbaum MA; Masaryk T; Mazzone P; Mekhail T; Fazio V; McCartney S; Marchi N; Kanner A; Janigro D
Cancer; 2005 Aug; 104(4):817-24. PubMed ID: 15971200
[TBL] [Abstract][Full Text] [Related]
3. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions.
Kanner AA; Marchi N; Fazio V; Mayberg MR; Koltz MT; Siomin V; Stevens GH; Masaryk T; Aumayr B; Vogelbaum MA; Barnett GH; Janigro D
Cancer; 2003 Jun; 97(11):2806-13. PubMed ID: 12767094
[TBL] [Abstract][Full Text] [Related]
4. Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption.
Marchi N; Fazio V; Cucullo L; Kight K; Masaryk T; Barnett G; Vogelbaum M; Kinter M; Rasmussen P; Mayberg MR; Janigro D
J Neurosci; 2003 Mar; 23(5):1949-55. PubMed ID: 12629200
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of S100B protein as a serum marker of brain metastasis in non-small cell lung cancer and its prognostic value.
Chen L; Hu X; Wu H; Jia Y; Liu J; Mu X; Wu H; Zhao Y
Pathol Res Pract; 2019 Mar; 215(3):427-432. PubMed ID: 30455129
[TBL] [Abstract][Full Text] [Related]
6. Peripheral detection of S100beta during cardiothoracic surgery: what are we really measuring?
Fazio V; Bhudia SK; Marchi N; Aumayr B; Janigro D
Ann Thorac Surg; 2004 Jul; 78(1):46-52; discussion 52-3. PubMed ID: 15223400
[TBL] [Abstract][Full Text] [Related]
7. Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
Li BT; Lou E; Hsu M; Yu HA; Naidoo J; Zauderer MG; Sima C; Johnson ML; Daras M; DeAngelis LM; Fleisher M; Kris MG; Azzoli CG
PLoS One; 2016; 11(1):e0146063. PubMed ID: 26730601
[TBL] [Abstract][Full Text] [Related]
8. Peripheral markers of brain damage and blood-brain barrier dysfunction.
Marchi N; Rasmussen P; Kapural M; Fazio V; Kight K; Mayberg MR; Kanner A; Ayumar B; Albensi B; Cavaglia M; Janigro D
Restor Neurol Neurosci; 2003; 21(3-4):109-21. PubMed ID: 14530574
[TBL] [Abstract][Full Text] [Related]
9. Identification of serum proteome components associated with progression of non-small cell lung cancer.
Pietrowska M; Jelonek K; Michalak M; Roś M; Rodziewicz P; Chmielewska K; Polański K; Polańska J; Gdowicz-Kłosok A; Giglok M; Suwiński R; Tarnawski R; Dziadziuszko R; Rzyman W; Widłak P
Acta Biochim Pol; 2014; 61(2):325-31. PubMed ID: 24872961
[TBL] [Abstract][Full Text] [Related]
10. The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer.
Sun D; Li X; Ma M; Liu J; Xu Y; Ye L; Hou H; Wang C; Li X; Jiang Y
Jpn J Clin Oncol; 2015 May; 45(5):464-73. PubMed ID: 25646356
[TBL] [Abstract][Full Text] [Related]
11. Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.
Okano T; Seike M; Kuribayashi H; Soeno C; Ishii T; Kida K; Gemma A
Int J Oncol; 2016 Mar; 48(3):945-52. PubMed ID: 26783151
[TBL] [Abstract][Full Text] [Related]
12. [Proteomics-based identification of proapoptotic caspase adapter protein as a novel serum marker of non-small cell lung cancer].
Zhang H; Chen S; Huang L
Zhongguo Fei Ai Za Zhi; 2012 May; 15(5):287-93. PubMed ID: 22613335
[TBL] [Abstract][Full Text] [Related]
13. Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
Darlix A; Lamy PJ; Lopez-Crapez E; Braccini AL; Firmin N; Romieu G; Thézenas S; Jacot W
Int J Cancer; 2016 Nov; 139(10):2299-311. PubMed ID: 27464303
[TBL] [Abstract][Full Text] [Related]
14. Can we define any marker associated with brain failure in patients with locally advanced non-small cell lung cancer?
Sert F; Cosgun G; Yalman D; Ozkok S
Cancer Radiother; 2021 Jun; 25(4):316-322. PubMed ID: 33422415
[TBL] [Abstract][Full Text] [Related]
15. Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
Jin Z; Jin RH; Ma C; Li HS; Xu HY
J BUON; 2017; 22(2):474-480. PubMed ID: 28534372
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
[TBL] [Abstract][Full Text] [Related]
17. Blood-brain-barrier disruption in chronic canine hypothyroidism.
Pancotto T; Rossmeisl JH; Panciera DL; Zimmerman KL
Vet Clin Pathol; 2010 Dec; 39(4):485-93. PubMed ID: 20874830
[TBL] [Abstract][Full Text] [Related]
18. Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI.
Yokoi K; Kamiya N; Matsuguma H; Machida S; Hirose T; Mori K; Tominaga K
Chest; 1999 Mar; 115(3):714-9. PubMed ID: 10084481
[TBL] [Abstract][Full Text] [Related]
19. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
[TBL] [Abstract][Full Text] [Related]
20. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
